Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

In two trials involving patients with irritable bowel syndrome without constipation, 2 weeks of treatment with the minimally absorbed antibiotic rifaximin was more effective than placebo in providing adequate relief of symptoms. The irritable bowel syndrome (IBS) is a functional gastrointestinal dis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2011-01, Vol.364 (1), p.22-32
Hauptverfasser:	Pimentel, Mark, Lembo, Anthony, Chey, William D, Zakko, Salam, Ringel, Yehuda, Yu, Jing, Mareya, Shadreck M, Shaw, Audrey L, Bortey, Enoch, Forbes, William P
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Abdominal Pain - drug therapy Abdominal Pain - etiology Aged Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - therapeutic use Antibacterial agents Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Bowel disease Diarrhea - drug therapy Diarrhea - etiology Double-Blind Method Female Gastroenterology. Liver. Pancreas. Abdomen General aspects Humans Irritable bowel syndrome Irritable Bowel Syndrome - complications Irritable Bowel Syndrome - drug therapy Male Medical sciences Middle Aged Other diseases. Semiology Pain Pharmacology. Drug treatments Rifamycins - adverse effects Rifamycins - therapeutic use Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Thyroid diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!